GF/B52/DP05
Approved by the Board on: 21 November 2024
Allocation Methodology for the 2026-2028 allocation period (Grant Cycle 8)
Based on the recommendation of the Strategy Committee (the “SC”) as presented in GF/B52/08B, the Board:
- Acknowledges the decision by the SC in October 2024 GF/SC26/DP05, under authority delegated by the Board, to establish technical parameters for Grant Cycle 8 (the “Technical Parameters”); and
- Acknowledges that the total amount of funds available for country allocation (including approved sources of funds for country allocation and any additional funds approved as available for country allocation) will be decided by the Board in November 2025, based on the recommendation of the Audit and Finance Committee following announced replenishment results from the 8th Replenishment.
Accordingly, the Board:
- Approves the allocation methodology, including its global disease split, presented in Annex 1 to GF/B52/08B (the “Allocation Methodology”);
- Requests the SC to review and approve, in 2025, the method by which the Secretariat will apply and report on the qualitative adjustment process; and
- Acknowledges that the Allocation Methodology and Technical Parameters shall apply for Grant Cycle 8 and supersede the 2023-2025 allocation methodology and technical parameters presented in GF/B47/03.